LAWLIS V BRYAN
SEC CIK 1247681 · EDGAR
BoughtSold
Most active insiders at GERN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROBERTSON MICHELLE | EVP, CFO | — | $19.1K |
| 2 | Spiegel Robert J. | Dir | — | — |
LAWLIS V BRYAN made no open-market trades at GERN in the last 12 months.
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-13 | 2025-05-09 | GERN | GERON CORP | LAWLIS V BRYAN | Dir | P - Purchase | $1.18 | +13.3K | 13.3K | New | +$15.7K | |
| DT | 2024-05-17 | 2024-05-15 | GERN | GERON CORP | LAWLIS V BRYAN | Dir | S - Sale+OE | $3.75 | -35.0K | 0 | -100% | -$131.2K |
| DT | 2024-05-17 | 2024-05-15 | GERN | GERON CORP | LAWLIS V BRYAN | Dir | M - OptEx | $1.94 | +35.0K | 35.0K | New | +$67.9K |
| 2023-05-24 | 2023-05-23 | BMRN | BIOMARIN PHARMACEUTICAL INC | LAWLIS V BRYAN | Dir | A - Grant | $0.00 | +4,190 | 33.1K | +14% | $0 | |
| D | 2023-05-11 | 2023-05-11 | GERN | GERON CORP | LAWLIS V BRYAN | Dir | S - Sale+OE | $3.00 | -35.0K | 0 | -100% | -$105.0K |
| D | 2023-05-11 | 2023-05-11 | GERN | GERON CORP | LAWLIS V BRYAN | Dir | M - OptEx | $1.10 | +35.0K | 35.0K | New | +$38.5K |
| D | 2023-04-04 | 2023-04-03 | BMRN | BIOMARIN PHARMACEUTICAL INC | LAWLIS V BRYAN | Dir | M - OptEx | $67.81 | +8,500 | 37.5K | +29% | +$576.4K |
| D | 2023-04-04 | 2023-04-03 | BMRN | BIOMARIN PHARMACEUTICAL INC | LAWLIS V BRYAN | Dir | S - Sale+OE | $97.09 | -8,500 | 28.9K | -23% | -$825.3K |
| 2022-05-26 | 2022-05-24 | BMRN | BIOMARIN PHARMACEUTICAL INC | LAWLIS V BRYAN | Dir | A - Grant | $0.00 | +4,980 | 28.9K | +21% | $0 | |
| D | 2022-04-18 | 2022-04-14 | BMRN | BIOMARIN PHARMACEUTICAL INC | LAWLIS V BRYAN | Dir | S - Sale+OE | $83.66 | -4,250 | 24.0K | -15% | -$355.6K |
| D | 2022-04-18 | 2022-04-14 | BMRN | BIOMARIN PHARMACEUTICAL INC | LAWLIS V BRYAN | Dir | M - OptEx | $37.46 | +4,250 | 28.2K | +18% | +$159.2K |
| D | 2022-01-19 | 2022-01-14 | BMRN | BIOMARIN PHARMACEUTICAL INC | LAWLIS V BRYAN | Dir | S - Sale+OE | $87.61 | -4,250 | 24.0K | -15% | -$372.3K |
| D | 2022-01-19 | 2022-01-14 | BMRN | BIOMARIN PHARMACEUTICAL INC | LAWLIS V BRYAN | Dir | M - OptEx | $37.46 | +4,250 | 28.2K | +18% | +$159.2K |
Purchase Sale Sale after option exercise All abbreviations